Logo

American Heart Association

  8
  0


Final ID: TP253

Can the clot meniscus and claw signs predict thrombectomy and clinical outcomes in stroke patients? A Systematic Review and Meta-Analysis

Abstract Body: ABSTRACT
Background: Angiographic shape of occlusion, like the clot meniscus sign and the claw-sign, have been reported to potentially impact recanalization rate and clinical outcome in patient undergoing mechanical thrombectomy for acute ischemic strokes.
Method: Following PRISMA guidelines, a systematic literature search was conducted across PubMed, Scopus, and Web of Science databases. Patients were grouped into clot meniscus/claw sign positive and negative groups based on the definitions obtained from each study. Primary outcomes included technical success, with a meta-analysis performed using a random-effects model to calculate proportions and odds ratios (OR) with 95% confidence intervals (Cl).
Results: We included seven studies recruiting 1572 patients. The results indicated that the positive and negative groups had comparable first-pass effect (OR: 1.95; 95%CI: 0.76 – 5.01; P = 0.167) and final recanalization (OR: 1.36; 95%CI: 0.81 – 2.27; P = 0.248) rates. However, the rate of having a favorable functional outcome was significantly higher in the positive than negative sign groups (OR: 1.91; 95%CI: 1.25 – 2.92; P < 0.003). Within the sign-positive population, the use of contact aspiration was associated with a significantly higher rate of recanalization compared to using a stent retriever (OR: 0.18; 95%CI: 0.07 – 0.49; P < 0.001). This result did not translate into a clinical impact, as both stent retriever and contact aspiration showed comparable rates of functional independence at three months (OR: 0.22; 95%CI: 0.02 – 2.33; P = 0.210).
Conclusion: The presence of the clot meniscus/claw sign is not associated with recanalization outcomes after thrombectomy. However, it might be a good sign to predict which thrombectomy technique might be associated with better recanalization, although current evidence might need further confirmation.
  • Reda, Abdullah  ( Mayo Clinic, Rochester, Minnesota; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota. , Rochester , Minnesota , United States )
  • Cortese, Jonathan  ( Bicetre University-Hospital, Le Kremlin-Bicetre, France , Paris , France )
  • Gajjar, Aryan  ( Mayo Clinic, Rochester, Minnesota; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota. , Rochester , Minnesota , United States )
  • Douri, Dani  ( Mayo Clinic, Rochester, Minnesota; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota. , Rochester , Minnesota , United States )
  • Ghozy, Sherief  ( Mayo Clinic, Rochester, Minnesota; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota. , Rochester , Minnesota , United States )
  • Kallmes, David  ( Mayo Clinic, Rochester, Minnesota; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota. , Rochester , Minnesota , United States )
  • Author Disclosures:
    Abdullah Reda: No Answer | Jonathan Cortese: No Answer | Aryan Gajjar: DO NOT have relevant financial relationships | Dani Douri: No Answer | Sherief Ghozy: DO NOT have relevant financial relationships | David Kallmes: DO have relevant financial relationships ; Individual Stocks/Stock Options:Piraeus Medical:Active (exists now) ; Research Funding (PI or named investigator):Stryker:Past (completed) ; Research Funding (PI or named investigator):Medical Device Engineering:Active (exists now) ; Research Funding (PI or named investigator):Octapharma:Active (exists now) ; Research Funding (PI or named investigator):Sensome:Active (exists now) ; Research Funding (PI or named investigator):Cerenovus:Active (exists now) ; Ownership Interest:Superior Medical Editors:Active (exists now) ; Individual Stocks/Stock Options:Nested Knowledge:Active (exists now) ; Ownership Interest:Conway Medical:Active (exists now)
Meeting Info:
Session Info:

Neuroendovascular Posters II

Thursday, 02/06/2025 , 07:00PM - 07:30PM

Poster Abstract Session

More abstracts on this topic:
A retrospective analysis of Tenecteplase vs Alteplase for the treatment of central retinal artery occlusion

Vo Alexander, Rho Howard, Sangha Navi, Khrlobyan Manya, Han Seungyong, Modjtahedi Bobeck, Taleb Shayandokht, Cheng Pamela, Ajani Zahra, Le Duy, Ly An

A Novel Thrombolytic with Anti-inflammatory Properties (JX10) Improves Neurological Outcomes in Acute Lacunar Infarct up to 12 hours After Onset

Chen Edmond, Niizuma Kuniyasu, Nitika Fnu, Hasumi Keiji, Tominaga Teiji, Nishimura Naoko, Zhang Shenglin

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)